Table 1 The demographic and clinical outcome of all participants
PD Patients (n = 27) | Healthy controls (n = 23) | p-value | |
|---|---|---|---|
Age (years) | 68.9 ± 9.2 | 65.9 ± 7.2 | 0.21a |
Gender (male/female) | 10/17 | 8/15 | 0.87b |
Disease duration (years) | 3.6 ± 2.9 | NA | NA |
Clinically dominant side (left/right) | 14/13 | NA | NA |
H&Y stage | 2.1 ± 0.7 | NA | NA |
MDS-UPDRS part I | 10.8 ± 8.7 | NA | NA |
MDS-UPDRS part II | 12.2 ± 7.3 | NA | NA |
MDS-UPDRS part III | 30.7 ± 13.2 | NA | NA |
MDS-UPDRS part IV | 0.9 ± 2.3 | NA | NA |